Patent applications aside, GBLX is building a growing network with an emphasis on high quality, consistent MJ strains that can and will be used in the medical field. They also have their hands in the recreational sector. Both of these industry ventures are ramping up to start producing revenue. So far, the debt and share structures are decent. As long as they don't start rifling money into the pockets of the leadership this has all the workings of a well built company that should do well in the future. IMO of course.